BioNTech Company
We guide you through the promising world of immunotherapies. Find info on basic research and new developments of new treatment options.
Investors
.png)
.png)
Industry:
mRNA-based Cancer Vaccines
Investors Number:
4
Number Of Exists:
N/A
Technology:
COVID
Investor Type:
N/A
Last Funding Type:
Post-IPO Equity
Total Funding:
1741003260.0
Funding Status:
IPO
Acquisitions Number:
Made Acquisitions
Headquarters:
Mainz, Rheinland-Pfalz, Germany
Founded Date:
2008-01-01
Employee Number:
N/A
Investment Stage:
N/A
Last Funding Date:
2022-04-14
Estimated Revenue:
$100M to $500M